Discovery of aryl aminoquinazoline pyridones as potent selective, and orally efficacious inhibitors of receptor tyrosine kinase c-Kit

被引：38

作者：

Hu, Essa ^{[1
,7
]}

Tasker, Andrew ^{[1
,7
]}

White, Ryan D. ^{[1
,7
]}

Kunz, Roxanne K. ^{[1
,7
]}

Human, Jason ^{[1
,7
]}

Chen, Ning ^{[1
,7
]}

Buerli, Roland ^{[1
,7
]}

Hungate, Randall ^{[1
,7
]}

Novak, Perry ^{[5
,8
]}

Itano, Andrea ^{[2
]}

Zhang, Xuxia ^{[2
]}

Yu, Violeta ^{[3
]}

Nguyen, Yen ^{[3
]}

Tudor, Yanyan ^{[3
]}

Plant, Matthew ^{[2
]}

Flynn, Shaun ^{[3
]}

Xu, Yang ^{[4
]}

Meagher, Kristin L. ^{[6
]}

Whittington, Douglas A. ^{[6
]}

Ng, Gordon Y. ^{[2
]}

机构：

[1] Amgen Inc, Dept Med Chem, Thousand Oaks, CA 91320 USA

[2] Amgen Inc, Dept Inflammat, Thousand Oaks, CA 91320 USA

[3] Amgen Inc, Dept HTS & Mol Pharmacol, Thousand Oaks, CA 91320 USA

[4] Amgen Inc, Dept Pharmacokinet & Drug Metab, Thousand Oaks, CA 91320 USA

[5] Amgen Inc, Dept Small Mol Proc Dev, Thousand Oaks, CA 91320 USA

[6] Amgen Inc, Dept Mol Struct, Thousand Oaks, CA 91320 USA

[7] Amgen Inc, Dept Med Chem, Cambridge, MA 02139 USA

[8] Amgen Inc, Dept Small Mol Proc Dev, Cambridge, MA 02139 USA

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 2008年 / 51卷 / 11期

关键词：

D O I：

10.1021/jm800188g

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Inhibition of c-Kit has the potential to treat mast cell associated fibrotic diseases. We report the discovery of several aminoquinazoline pyridones that are potent inhibitors of c-Kit with greater than 200-fold selectivity against KDR, p38, Lck, and Src. In vivo efficacy of pyridone 16 by dose-dependent inhibition of histamine release was demonstrated in a rodent pharmacodynamic model of mast cell activation.

引用

页码：3065 / 3068

页数：4

共 50 条

[41] Signal transduction of c-Kit receptor tyrosine kinase in CHRF myeloid leukemia cells
Scholl, S
Kirsch, C
Böhmer, FD
Klinger, R
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2004, 130 (12) : 711 - 718
[42] Signal transduction of c-Kit receptor tyrosine kinase in CHRF myeloid leukemia cells
Sebastian Scholl
Cornelia Kirsch
Frank D. Böhmer
Reinhard Klinger
Journal of Cancer Research and Clinical Oncology, 2004, 130 : 711 - 718
[43] Selective pharmacological inhibition of wild type and mutant c-kit receptor tyrosine kinase activity in hematopoietic cells.
Heinrich, M
Zigler, A
Griffith, D
Druker, B
Wait, C
Ott, K
BLOOD, 1999, 94 (10) : 62A - 62A
[44] Potent and selective Bruton's tyrosine kinase inhibitors: Discovery of GDC-0834
Young, Wendy B.
Barbosa, James
Blomgren, Peter
Bremer, Meire C.
Crawford, James J.
Dambach, Donna
Gallion, Steve
Hymowitz, Sarah G.
Kropf, Jeffrey E.
Lee, Seung H.
Liu, Lichuan
Lubach, Joseph W.
Macaluso, Jen
Maciejewski, Pat
Maurer, Brigitte
Mitchell, Scott A.
Ortwine, Daniel F.
Di Paolo, Julie
Reif, Karin
Scheerens, Heleen
Schmitt, Aaron
Sowell, C. Gregory
Wang, Xiaojing
Wong, Harvey
Xiong, Jin-Ming
Xu, Jianjun
Zhao, Zhongdong
Currie, Kevin S.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2015, 25 (06) : 1333 - 1337
[45] Discovery of LAS101057: A Potent, Selective, and Orally Efficacious A2B Adenosine Receptor Antagonist
Eastwood, Paul
Esteve, Cristina
Gonzalez, Jacob
Fonquerna, Silvia
Aiguade, Josep
Carranco, Ines
Domenech, Teresa
Aparici, Monica
Miralpeix, Montserrat
Alberti, Joan
Cordoba, Monica
Fernandez, Raquel
Pont, Merce
Godessart, Nuria
Prats, Neus
Isabel Loza, Maria
Isabel Cadavid, Maria
Nueda, Arsenio
Vidal, Bernat
ACS MEDICINAL CHEMISTRY LETTERS, 2011, 2 (03): : 213 - 218
[46] Tyrosine Kinase Inhibitors Induce Down-Regulation of c-Kit by Targeting the ATP Pocket
D'allard, Diane
Gay, Julie
Descarpentries, Clotilde
Frisan, Emilie
Adam, Kevin
Verdier, Frederique
Floquet, Celia
Dubreuil, Patrice
Lacombe, Catherine
Fontenay, Michaela
Mayeux, Patrick
Kosmider, Olivier
PLOS ONE, 2013, 8 (04):
[47] The receptor tyrosine kinase c-Kit controls IL-33 receptor signaling in mast cells
Drube, Sebastian
Heink, Sylvia
Walter, Sabine
Loehn, Tobias
Grusser, Mandy
Gerbaulet, Alexander
Berod, Luciana
Schons, Julia
Dudeck, Anne
Freitag, Jenny
Grotha, Stefan
Reich, Daniela
Rudeschko, Olga
Norgauer, Johannes
Hartmann, Karin
Roers, Axel
Kamradt, Thomas
BLOOD, 2010, 115 (19) : 3899 - 3906
[48] Discovery and Evaluation of 7-Alkyl-1,5-bis-aryl-pyrazolopyridinones as Highly Potent, Selective, and Orally Efficacious Inhibitors of p38α Mitogen-Activated Protein Kinase
Pettus, Liping H.
Wurz, Ryan P.
Xu, Shimin
Herberich, Brad
Henkle, Bradley
Liu, Qiurong
McBride, Helen J.
Mu, Sharon
Plant, Matthew H.
Saris, Christiaan J. M.
Sherman, Lisa
Wong, Lu Min
Chmait, Samer
Lee, Matthew R.
Mohr, Christopher
Hsieh, Faye
Tasker, Andrew S.
JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (07) : 2973 - 2985
[49] Discovery of AS-1763: A Potent, Selective, Noncovalent, and Orally Available Inhibitor of Bruton's Tyrosine Kinase
Kawahata, Wataru
Asami, Tokiko
Kiyoi, Takao
Irie, Takayuki
Kashimoto, Shigeki
Furuichi, Hatsuo
Sawa, Masaaki
JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (19) : 14129 - 14141
[50] MECHANISM OF DOWN-REGULATION OF C-KIT RECEPTOR - ROLES OF RECEPTOR TYROSINE KINASE, PHOSPHATIDYLINOSITOL 3'-KINASE, AND PROTEIN-KINASE-C
YEE, NS
HSIAU, CWM
SERVE, H
VOSSELLER, K
BESMER, P
JOURNAL OF BIOLOGICAL CHEMISTRY, 1994, 269 (50) : 31991 - 31998

← 1 2 3 4 5 →